Back to results
US 2017/0281623 A1Published application
Solid forms of an epidermal growth factor receptor kinase inhibitor
AssigneeCelgene CAR LLC
InventorMei Lai
Life of this patent
Estimating the term…
Abstract
The present invention provides a solid form and composites thereof, which are useful as an inhibitor of EGFR kinases and which exhibit desirable characteristics for the same.
Claims21
1-33. (canceled)
A composition comprising a solid form of Compound 1:
- wherein the solid form of Compound 1 is selected from the group consisting of Form A, Form B, Form C, Form D, Form E, Form F, Form G, Form H, and Form I;
- and
- wherein the composition is substantially free of impurities.
A composition comprising Compound 1:
- wherein Compound 1 is a crystalline solid form substantially free of an amorphous form of Compound 1.
Dependencies are inferred from the claim text.